Intrinsic toll-like receptor signalling drives regulatory function in B cells

Frontiers in Bioscience - Elite

Volumn 5 E, Issue 1, 2013, Pages 78-86

  Shen, Ping ^a   Lampropoulou, Vicky ^a   Stervbo, Ulrik ^a   Hilgenberg, Ellen ^a   Ries, Stefanie ^a   Mecqinion, Aurelie ^a   Fillatreau, Simon ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Autoimmunity; B cell; Cell therapy; Infection; Interleukin 10; Review; Tolerance; Toll like receptor

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; B LYMPHOCYTE; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; INFECTION; LYMPHOCYTE FUNCTION; NONHUMAN; SALMONELLOSIS; SECONDARY IMMUNE RESPONSE; SIGNAL TRANSDUCTION; COMMUNICABLE DISEASE; IMMUNOLOGY; METABOLISM; REVIEW;

B-LYMPHOCYTES; COMMUNICABLE DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

MLCS; MLOWN;

EID: 84878495658     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e597     Document Type: Article

References (87)

1. D. P. Harris, L. Haynes, P. C. Sayles, D. K. Duso, S. M. Eaton, N. M. Lepak, L. L. Johnson, S. L. Swain and F. E. Lund: Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol, 1(6), 475-82 (2000)
2. V. Lampropoulou, K. Hoehlig, T. Roch, P. Neves, E. Calderon Gomez, C. H. Sweenie, Y. Hao, A. A. Freitas, U. Steinhoff, S. M. Anderton and S. Fillatreau: TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol, 180(7), 4763-73 (2008)
3. K. Hoehlig, V. Lampropoulou, T. Roch, P. Neves, E. Calderon-Gomez, S. M. Anderton, U. Steinhoff and S. Fillatreau: Immune regulation by B cells and antibodies a view towards the clinic. Adv Immunol, 98, 1-38 (2008)
4. P. Neves, V. Lampropoulou, E. Calderon-Gomez, T. Roch, U. Stervbo, P. Shen, A. A. Kuhl, C. Loddenkemper, M. Haury, S. A. Nedospasov, S. H. Kaufmann, U. Steinhoff, D. P. Calado and S. Fillatreau: Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity, 33(5), 777-90 (2010)
5. S. Fillatreau, C. H. Sweenie, M. J. McGeachy, D. Gray and S. M. Anderton: B cells regulate autoimmunity by provision of IL-10. Nat Immunol, 3(10), 944-50 (2002) doi:10.1038/ni833 (Pubitemid 35154008)
6. A. Mizoguchi, E. Mizoguchi, H. Takedatsu, R. S. Blumberg and A. K. Bhan: Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity, 16(2), 219-30 (2002) (Pubitemid 34211962)
7. C. Mauri, D. Gray, N. Mushtaq and M. Londei: Prevention of arthritis by interleukin 10-producing B cells. J Exp Med, 197(4), 489-501 (2003) (Pubitemid 36278604)
8. S. Fillatreau, D. Gray and S. M. Anderton: Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol, 8(5), 391-7 (2008) (Pubitemid 351595221)
9. S. M. Anderton and S. Fillatreau: Activated B cells in autoimmune diseases: the case for a regulatory role. Nat Clin Pract Rheumatol, 4(12), 657-66 (2008)
10. V. Lampropoulou, E. Calderon-Gomez, T. Roch, P. Neves, P. Shen, U. Stervbo, P. Boudinot, S. M. Anderton and S. Fillatreau: Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. Immunol Rev, 233(1), 146-61 (2010)
11. M. E. Duddy, A. Alter and A. Bar-Or: Distinct profiles of human B cell effector cytokines: a role in immune regulation? J Immunol, 172(6), 3422-7 (2004) (Pubitemid 38337921)
12. M. Duddy, M. Niino, F. Adatia, S. Hebert, M. Freedman, H. Atkins, H. J. Kim and A. Bar-Or: Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol, 178(10), 6092-9 (2007) (Pubitemid 46717389)
13. L. Steinman: Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron, 24(3), 511-4 (1999)
14. S. Fillatreau and S. M. Anderton: B-cell function in CNS inflammatory demyelinating disease: a complexity of roles and a wealth of possibilities. Expert Rev Clin Immunol, 3(4), 565-78 (2007) (Pubitemid 47091232)
15. M. K. Waldor, S. Sriram, R. Hardy, L. A. Herzenberg, L. Lanier, M. Lim and L. Steinman: Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science, 227(4685), 415-7 (1985) (Pubitemid 15153498)
16. A. Ben-Nun, H. Wekerle and I. R. Cohen: The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol, 11(3), 195-9 (1981) (Pubitemid 11104096)
17. J. R. Oksenberg, S. E. Baranzini, S. Sawcer and S. L. Hauser: The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet, 9(7), 516-26 (2008) (Pubitemid 351861542)
18. S. L. Hauser, E. Waubant, D. L. Arnold, T. Vollmer, J. Antel, R. J. Fox, A. Bar-Or, M. Panzara, N. Sarkar, S. Agarwal, A. Langer-Gould and C. H. Smith: B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med, 358(7), 676-88 (2008) (Pubitemid 351240747)
19. T. Matsushita, K. Yanaba, J. D. Bouaziz, M. Fujimoto and T. F. Tedder: Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest, 118(10), 3420-30 (2008)
20. S. D. Wolf, B. N. Dittel, F. Hardardottir and C. A. Janeway, Jr.: Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med, 184(6), 2271-8 (1996) (Pubitemid 27023727)
21. H. Park, Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian and C. Dong: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol, 6(11), 1133-41 (2005) (Pubitemid 41541791)
22. V. K. Kuchroo, C. A. Martin, J. M. Greer, S. T. Ju, R. A. Sobel and M. E. Dorf: Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol, 151(8), 4371-82 (1993) (Pubitemid 23298771)
23. A. Mizoguchi, E. Mizoguchi and A. K. Bhan: The critical role of interleukin 4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor alpha mutant mice. Gastroenterology, 116(2), 320-6 (1999) (Pubitemid 29055354)
24. L. Svensson, J. Jirholt, R. Holmdahl and L. Jansson: B cell-deficient mice do not develop type II collageninduced arthritis (CIA). Clin Exp Immunol, 111(3), 521-6 (1998) (Pubitemid 28160894)
25. K. Yanaba, J. D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto and T. F. Tedder: A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T celldependent inflammatory responses. Immunity, 28(5), 639-50 (2008) (Pubitemid 351636247)
26. K. Yanaba, J. D. Bouaziz, T. Matsushita, T. Tsubata and T. F. Tedder: The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol, 182(12), 7459-72 (2009)
27. C. M. Sun, E. Deriaud, C. Leclerc and R. Lo-Man: Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity, 22(4), 467-77 (2005) (Pubitemid 40545112)
28. J. G. Evans, K. A. Chavez-Rueda, A. Eddaoudi, A. Meyer-Bahlburg, D. J. Rawlings, M. R. Ehrenstein and C. Mauri: Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol, 178(12), 7868-78 (2007) (Pubitemid 46898059)
29. F. Martin and J. F. Kearney: B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol, 13(2), 195-201 (2001) (Pubitemid 32176039)
30. M. Goetz, R. Atreya, M. Ghalibafian, P. R. Galle and M. F. Neurath: Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis, 13(11), 1365-8 (2007) (Pubitemid 350206846)
31. L. Benedetti, D. Franciotta, T. Vigo, M. Grandis, E. Fiorina, E. Ghiglione, L. Roccatagliata, G. L. Mancardi, A. Uccelli and A. Schenone: Relapses after treatment with rituximab in a patient with multiple sclerosis and anti myelin-associated glycoprotein polyneuropathy. Arch Neurol, 64(10), 1531-3 (2007) (Pubitemid 47572681)
32. D. El Fassi, C. H. Nielsen, J. Kjeldsen, O. Clemmensen and L. Hegedus: Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease. Gut, 57(5), 714-5 (2008) (Pubitemid 351579988)
33. M. Hirotani, M. Niino, T. Fukazawa, S. Kikuchi, I. Yabe, S. Hamada, Y. Tajima and H. Sasaki: Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis. J Neuroimmunol, 221(1-2), 95-100 (2010)
34. M. Jagannathan, M. McDonnell, Y. Liang, H. Hasturk, J. Hetzel, D. Rubin, A. Kantarci, T. E. Van Dyke, L. M. Ganley-Leal and B. S. Nikolajczyk: Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia, 53(7), 1461-71 (2010)
35. V. Hornung, S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdorfer, T. Giese, S. Endres and G. Hartmann: Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol, 168(9), 4531-7 (2002) (Pubitemid 34441357)
36. D. Rozkova, L. Novotna, R. Pytlik, I. Hochova, T. Kozak, J. Bartunkova and R. Spisek: Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation. Int J Cancer, 126(5), 1132-43 (2010)
37. H. Shin, Y. Zhang, M. Jagannathan, H. Hasturk, A. Kantarci, H. Liu, T. E. Van Dyke, L. M. Ganley-Leal and B. S. Nikolajczyk: B cells from periodontal disease patients express surface Toll-like receptor 4. J Leukoc Biol, 85(4), 648-55 (2009)
38. M. Jagannathan, H. Hasturk, Y. Liang, H. Shin, J. T. Hetzel, A. Kantarci, D. Rubin, M. E. McDonnell, T. E. Van Dyke, L. M. Ganley-Leal and B. S. Nikolajczyk: TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients. J Immunol, 183(11), 7461-70 (2009)
39. J. Correale and M. Farez: Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol, 61(2), 97-108 (2007) (Pubitemid 46363837)
40. J. Correale, M. Farez and G. Razzitte: Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol, 64(2), 187-99 (2008)
41. A. Rydstrom and M. J. Wick: Monocyte and neutrophil recruitment during oral Salmonella infection is driven by MyD88-derived chemokines. Eur J Immunol, 39(11), 3019-30 (2009)
42. P. Henneke, O. Takeuchi, R. Malley, E. Lien, R. R. Ingalls, M. W. Freeman, T. Mayadas, V. Nizet, S. Akira, D. L. Kasper and D. T. Golenbock: Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J Immunol, 169(7), 3970-7 (2002)
43. R. Medzhitov, P. Preston-Hurlburt and C. A. Janeway, Jr.: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 388(6640), 394-7 (1997) (Pubitemid 27334820)
44. S. Fillatreau: Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection. Immunol Rev, 240(1), 52-71 (2011)
45. H. W. Mittrucker and S. H. Kaufmann: Immune response to infection with Salmonella typhimurium in mice. J Leukoc Biol, 67(4), 457-63 (2000)
46. J. A. Crump, S. P. Luby and E. D. Mintz: The global burden of typhoid fever. Bull World Health Organ, 82(5), 346-53 (2004) (Pubitemid 38715071)
47. M. Shapiro-Shelef and K. Calame: Regulation of plasma-cell development. Nat Rev Immunol, 5(3), 230-42 (2005) (Pubitemid 40364824)
48. G. A. Martins, L. Cimmino, M. Shapiro-Shelef, M. Szabolcs, A. Herron, E. Magnusdottir and K. Calame: Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat Immunol, 7(5), 457-65 (2006)
49. M. A. Tam, A. Rydstrom, M. Sundquist and M. J. Wick: Early cellular responses to Salmonella infection: dendritic cells, monocytes, and more. Immunol Rev, 225, 140-62 (2008)
50. S. C. Smelt, S. E. Cotterell, C. R. Engwerda and P. M. Kaye: B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophilmediated tissue pathology. J Immunol, 164(7), 3681-8 (2000) (Pubitemid 30169823)
51. P. J. Maglione, J. Xu and J. Chan: B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis. J Immunol, 178(11), 7222-34 (2007) (Pubitemid 46847448)
52. M. P. Berry, C. M. Graham, F. W. McNab, Z. Xu, S. A. Bloch, T. Oni, K. A. Wilkinson, R. Banchereau, J. Skinner, R. J. Wilkinson, C. Quinn, D. Blankenship, R. Dhawan, J. J. Cush, A. Mejias, O. Ramilo, O. M. Kon, V. Pascual, J. Banchereau, D. Chaussabel and A. O'Garra: An interferoninducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature, 466(7309), 973-7 (2010)
53. E. Voog, F. Morschhauser and P. Solal-Celigny: Neutropenia in patients treated with rituximab. N Engl J Med, 348(26), 2691-4; discussion 2691-4 (2003)
54. O. Wolach, O. Bairey and M. Lahav: Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature. Medicine (Baltimore), 89(5), 308-18 (2010)
55. B. Terrier, M. Ittah, L. Tourneur, F. Louache, V. Soumelis, F. Lavie, N. Casadevall, S. Candon, A. Hummel, X. Mariette and A. Buzyn: Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery. Haematologica, 92(2), e20-3 (2007)
56. K. Dunleavy, F. Hakim, H. K. Kim, J. E. Janik, N. Grant, T. Nakayama, T. White, G. Wright, L. Kwak, R. Gress, G. Tosato and W. H. Wilson: B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis. Blood, 106(3), 795-802 (2005) (Pubitemid 41076417)
57. K. Chaiwatanatorn, N. Lee, A. Grigg, R. Filshie and F. Firkin: Delayed-onset neutropenia associated with rituximab therapy. Br J Haematol, 121(6), 913-8 (2003) (Pubitemid 36760311)
58. Y. Ueda, M. Kondo and G. Kelsoe: Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J Exp Med, 201(11), 1771-80 (2005) (Pubitemid 41002896)
59. E. J. Fuchs and P. Matzinger: B cells turn off virgin but not memory T cells. Science, 258(5085), 1156-9 (1992)
60. E. T. Zambidis, A. Kurup and D. W. Scott: Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes. Mol Med, 3(3), 212-24 (1997) (Pubitemid 27215287)
61. B. Xu and D. W. Scott: A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP. Clin Immunol, 111(1), 47-52 (2004) (Pubitemid 38482081)
62. M. E. Melo, J. Qian, M. El-Amine, R. K. Agarwal, N. Soukhareva, Y. Kang and D. W. Scott: Gene transfer of Igfusion proteins into B cells prevents and treats autoimmune diseases. J Immunol, 168(9), 4788-95 (2002) (Pubitemid 34441388)
63. W. Liang, Z. Karabekian, M. Mattapallil, Q. Xu, A. M. Viley, R. Caspi and D. W. Scott: B-cell delivered gene transfer of human S-Ag-Ig fusion protein protects from experimental autoimmune uveitis. Clin Immunol, 118(1), 35-41 (2006) (Pubitemid 43012044)
64. R. K. Agarwal, Y. Kang, E. Zambidis, D. W. Scott, C. C. Chan and R. R. Caspi: Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J Clin Invest, 106(2), 245-52 (2000) (Pubitemid 30483128)
65. L. Song, J. Wang, R. Wang, M. Yu, Y. Sun, G. Han, Y. Li, J. Qian, D. W. Scott, Y. Kang, N. Soukhareva and B. Shen: Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta? Gene Ther, 11(20), 1487-96 (2004) (Pubitemid 39359456)
66. N. Soukhareva, Y. Jiang and D. W. Scott: Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of T regulatory cells. Cell Immunol, 240(1), 41-6 (2006) (Pubitemid 44286750)
67. M. S. Anderson and J. A. Bluestone: The NOD mouse: a model of immune dysregulation. Annu Rev Immunol, 23, 447-85 (2005) (Pubitemid 40563177)
68. T. Wong and M. Recht: Current options and new developments in the treatment of haemophilia. Drugs, 71(3), 305-20 (2011)
69. L. W. Hoyer: Hemophilia A. N Engl J Med, 330(1), 38-47 (1994) (Pubitemid 24018616)
70. T. C. Lei and D. W. Scott: Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins. Blood, 105(12), 4865-70 (2005) (Pubitemid 40812408)
71. M. G. Jacquemin and J. M. Saint-Remy: Factor VIII alloantibodies in hemophilia. Curr Opin Hematol, 11(3), 146-50 (2004) (Pubitemid 38952001)
72. K. P. Pratt, J. Qian, E. Ellaban, D. K. Okita, B. M. Diethelm-Okita, B. Conti-Fine and D. W. Scott: Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site. Thromb Haemost, 92(3), 522-8 (2004) (Pubitemid 39255359)
73. P. Bretscher and M. Cohn: A theory of self-nonself discrimination. Science, 169(950), 1042-9 (1970)
74. C. A. Janeway, Jr.: Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol, 54 Pt 1, 1-13 (1989) (Pubitemid 20177564)
75. E. T. Zambidis, R. K. Barth and D. W. Scott: Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients. J Immunol, 158(5), 2174-82 (1997) (Pubitemid 127470000)
76. M. El-Amine, M. Melo, Y. Kang, H. Nguyen, J. Qian and D. W. Scott: Mechanisms of tolerance induction by a gene-transferred peptide-IgG fusion protein expressed in B lineage cells. J Immunol, 165(10), 5631-6 (2000)
77. M. T. Litzinger, Y. Su, T. C. Lei, N. Soukhareva and D. W. Scott: Mechanisms of gene therapy for tolerance: B7 signaling is required for peptide-IgG gene-transferred tolerance induction. J Immunol, 175(2), 780-7 (2005) (Pubitemid 41094959)
78. T. C. Lei, Y. Su and D. W. Scott: Tolerance induction via a B-cell delivered gene therapy-based protocol: optimization and role of the Ig scaffold. Cell Immunol, 235(1), 12-20 (2005) (Pubitemid 41483029)
79. J. Skupsky, A. H. Zhang, Y. Su and D. W. Scott: Bcelldelivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cells. Mol Ther, 18(8), 1527-35 (2010)
80. R. R. Ahangarani, W. Janssens, L. VanderElst, V. Carlier, T. VandenDriessche, M. Chuah, B. Weynand, J. A. Vanoirbeek, M. Jacquemin and J. M. Saint-Remy: In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsiveness. J Immunol, 183(12), 8232-43 (2009)
81. Y. Su, A. H. Zhang, N. Noben-Trauth and D. W. Scott: B-Cell Gene Therapy for Tolerance Induction: Host but Not Donor B-Cell Derived IL-10 is Necessary for Tolerance. Front Microbiol, 2, 154 (2011)
82. J. N. Kline, T. J. Waldschmidt, T. R. Businga, J. E. Lemish, J. V. Weinstock, P. S. Thorne and A. M. Krieg: Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol, 160(6), 2555-9 (1998) (Pubitemid 28136702)
83. V. V. Jain, K. Kitagaki, T. Businga, I. Hussain, C. George, P. O'Shaughnessy and J. N. Kline: CpGoligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. J Allergy Clin Immunol, 110(6), 867-72 (2002) (Pubitemid 36005873)
84. K. Kitagaki, V. V. Jain, T. R. Businga, I. Hussain and J. N. Kline: Immunomodulatory effects of CpG oligodeoxynucleotides on established th2 responses. Clin Diagn Lab Immunol, 9(6), 1260-9 (2002) (Pubitemid 35283289)
85. P. S. Creticos, J. T. Schroeder, R. G. Hamilton, S. L. Balcer-Whaley, A. P. Khattignavong, R. Lindblad, H. Li, R. Coffman, V. Seyfert, J. J. Eiden and D. Broide: Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med, 355(14), 1445-55 (2006) (Pubitemid 44511559)
86. D. Miyazaki, C. H. Kuo, T. Tominaga, Y. Inoue and S. J. Ono: Regulatory function of CpG-activated B cells in late-phase experimental allergic conjunctivitis. Invest Ophthalmol Vis Sci, 50(4), 1626-35 (2009)
87. N. E. Mangan, R. E. Fallon, P. Smith, N. van Rooijen, A. N. McKenzie and P. G. Fallon: Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J Immunol, 173(10), 6346-56 (2004) (Pubitemid 39487794)